1. Home
  2. RGEN vs NCLH Comparison

RGEN vs NCLH Comparison

Compare RGEN & NCLH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$166.25

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Logo Norwegian Cruise Line Holdings Ltd.

NCLH

Norwegian Cruise Line Holdings Ltd.

HOLD

Current Price

$22.47

Market Cap

10.7B

ML Signal

HOLD

Company Overview

Basic Information
Metric
RGEN
NCLH
Founded
1981
1966
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Marine Transportation
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
8.2B
10.7B
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
RGEN
NCLH
Price
$166.25
$22.47
Analyst Decision
Buy
Buy
Analyst Count
10
18
Target Price
$174.90
$28.11
AVG Volume (30 Days)
617.0K
17.1M
Earning Date
02-19-2026
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
11.76
EPS
0.03
1.40
Revenue
$707,890,000.00
$9,692,558,000.00
Revenue This Year
$17.84
$6.85
Revenue Next Year
$12.44
$10.26
P/E Ratio
$6,513.01
$16.04
Revenue Growth
11.74
3.59
52 Week Low
$102.97
$14.21
52 Week High
$182.52
$29.29

Technical Indicators

Market Signals
Indicator
RGEN
NCLH
Relative Strength Index (RSI) 58.47 60.30
Support Level $161.41 $22.15
Resistance Level $167.65 $24.32
Average True Range (ATR) 4.50 0.86
MACD 0.15 0.19
Stochastic Oscillator 87.72 67.56

Price Performance

Historical Comparison
RGEN
NCLH

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About NCLH Norwegian Cruise Line Holdings Ltd.

Norwegian Cruise Line is the world's third-largest publicly traded cruise company by berths (around 71,000). It operates 34 ships across three brands—Norwegian, Oceania, and Regent Seven Seas—offering both freestyle and luxury cruising. The company redeployed its entire fleet as of May 2022. With 13 passenger vessels on order among its brands through 2036, representing 38,400 incremental berths, Norwegian is increasing capacity faster than its peers, expanding its brand globally. Norwegian sails to around 700 global destinations.

Share on Social Networks: